Reply by Authors

Affiliations

¹ Department of Surgery, Faculty of Medicine, Université Laval; Centre de recherche CHU de Québec-Université Laval, Oncology Division, Quebec City, Quebec, Canada.
² Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
³ Department of Surgery, Division of Radiation and Developmental Radiotherapeutics, University of British Columbia, BC Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada.
⁴ Canadian Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.
⁵ Department of Surgery, Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Comment

Samuel Tremblay et al. J Urol. 2021 Nov.

. 2021 Nov;206(5):1176.

doi: 10.1097/JU.0000000000001946.03. Epub 2021 Aug 12.

¹ Department of Surgery, Faculty of Medicine, Université Laval; Centre de recherche CHU de Québec-Université Laval, Oncology Division, Quebec City, Quebec, Canada.
² Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
³ Department of Surgery, Division of Radiation and Developmental Radiotherapeutics, University of British Columbia, BC Cancer Center for the Southern Interior, Kelowna, British Columbia, Canada.
⁴ Canadian Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.
⁵ Department of Surgery, Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

No abstract available

Comment on

Editorial Comment.
Crawford ED. Crawford ED. J Urol. 2021 Nov;206(5):1175. doi: 10.1097/JU.0000000000001946.01. Epub 2021 Aug 12. J Urol. 2021. PMID: 34383587 No abstract available.
Editorial Comment.
Wassersug R. Wassersug R. J Urol. 2021 Nov;206(5):1175-1176. doi: 10.1097/JU.0000000000001946.02. Epub 2021 Aug 12. J Urol. 2021. PMID: 34383588 No abstract available.